Skip to main navigation Skip to search Skip to main content
Philip Newsome

View Scopus Profile

Philip Newsome

Prof

 https://orcid.org/0000-0001-6085-3652

Accepting PhD Students

PhD projects

Dr Newsome is interested in supervising doctoral research in the following areas:

Contribution of adult stem cells to liver injury and repair
Non-alcoholic fatty liver disease; ranging from laboratory to clinical studies

20002025

Research activity per year

Personal profile

Research interests

Philip Newsome is Professor of Experimental Hepatology and Director of the Centre for Liver and GI Research. He is Deputy Director of the NIHR Birmingham Biomedical Research Centre.

He is Director of the Midlands & Wales Advanced Therapy Treatment Centre.

He is currently Secretary General of the European Association for the Study of the Liver and the Hepatology Vice-President of the British Society of Gastroenterology

Philip has published over 150 major research papers in scientific journals as well as reviews and book chapters in the fields of stem cell biology, NAFLD and liver disease. He has received major grants from NIHR, European Union, Wellcome Trust, UKSCF, BBSRC and the Medical Research Council.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 4 - Quality Education
    SDG 4 Quality Education

Fingerprint

Dive into the research topics where Philip Newsome is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease

    Lai, J.C.-T., Yang, B., Lee, H. W., Lin, H., Tsochatzis, E. A., Petta, S., Bugianesi, E., Yoneda, M., Zheng, M.-H., Hagström, H., Boursier, J., Calleja, J. L., Goh, G.B.-B., Chan, W.-K., Gallego-Duràn, R., Sanyal, A. J., de Lédinghen, V., Newsome, P. N., Fan, J.-G. & Castera, L. & 20 others, Lai, M., Fournier-Poizat, C., Wong, G.L.-H., Pennisi, G., Armandi, A., Nakajima, A., Liu, W.-Y., Shang, Y., Saint-Loup, M. D., Llop, E., Teh, K. K. J., Lara-Romero, C., Asgharpour, A., Mahgoub, S., Chan, M.S.-W., Canivet, C. M., Romero-Gómez, M., Kim, S. U., Wong, V.W.-S. & Yip, T.C.-F., 20 Jun 2025, (E-pub ahead of print) In: Gut.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    50 Downloads (Pure)

  • Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

    Sanyal, A. J., Newsome, P. N., Kliers, I., Østergaard, L. H., Long, M. T., Kjær, M. S., Cali, A. M. G., Bugianesi, E., Rinella, M. E., Roden, M., Ratziu, V. & ESSENCE Study Group, 5 Jun 2025, In: New England Journal of Medicine. 392, 21, p. 2089-2099 11 p.

    Research output: Contribution to journal › Article › peer-review

  • Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease

    Yip, T.C.-F., Lee, H. W., Lin, H., Tsochatzis, E., Petta, S., Bugianesi, E., Yoneda, M., Zheng, M.-H., Hagström, H., Boursier, J., Calleja, J. L., Goh, G.B.-B., Chan, W.-K., Gallego-Durán, R., Sanyal, A. J., de Lédinghen, V., Newsome, P. N., Fan, J.-G., Castéra, L. & Lai, M. & 18 others, Fournier-Poizat, C., Wong, G.L.-H., Pennisi, G., Armandi, A., Nakajima, A., Liu, W.-Y., Shang, Y., de Saint-Loup, M., Llop, E., Teh, K. K. J., Lara-Romero, C., Asgharpour, A., Mahgoub, S., Chan, M.S.-W., Canivet, C. M., Romero-Gomez, M., Kim, S. U. & Wong, V.W.-S., Aug 2025, In: Journal of Hepatology. 83, 2, p. 304-314 11 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    53 Downloads (Pure)

  • The Interplay Between Alcohol Consumption and Cardiometabolic Risk Factors in Individuals With MASLD and MetALD

    Yeo, Y. H., Rui, F., Zhu, Y., Xu, X., Ma, X., Ni, W., Sun, Y., Hu, X., Wu, C., Shi, J., Li, J. & Newsome, P. N., Sept 2025, In: Portal Hypertension & Cirrhosis. 4, 3, p. 157 - 166 10 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File

  • acFibroMASH index for the diagnosis of fibrotic MASH and prediction of liver-related events: An international multicenter study

    Feng, G., Mózes, F. E., Ji, D., Treeprasertsuk, S., Okanoue, T., Shima, T., Liang, H., Tsochatzis, E., Chen, J., Schattenberg, J. M., Labenz, C., Mahadeva, S., Chan, W. K., Chi, X., Delamarre, A., de Lédinghen, V., Petta, S., Bugianesi, E., Hagström, H. & Boursier, J. & 73 others, Calleja, J. L., Boon-Bee Goh, G., Gallego-Durán, R., Sanyal, A. J., Fan, J.-G., Castéra, L., Lai, M., Harrison, S. A., Romero-Gomez, M., Kim, S. U., Zhu, Y., Ooi, G., Shi, J., Yoneda, M., Nakajima, A., Lupsor-Platon, M., Zhong, B., Cobbold, J. F. L., Ye, C.-Y., Eddowes, P. J., Newsome, P., Li, J., George, J., He, F., Song, M. J., Tang, H., Fan, Y., Jia, J., Xu, L., Lin, S., Li, Y., Lu, Z., Nan, Y., Niu, J., Yan, X., Zhou, Y., Liu, C., Deng, H., Ye, Q., Zeng, Q.-L., Li, L., Wang, J., Yang, S., Lin, H., Lee, H. W., Cheuk-Fung Yip, T., Fournier-Poizat, C., Lai-Hung Wong, G., Pennisi, G., Armandi, A., Liu, W.-Y., Shang, Y., de Saint-Loup, M., Llop, E., Jun Teh, K. K., Romero, C.L., Asgharpour, A., Mahgoub, S., Sau-Wai Chan, M., Canivet, C. M., Ji, F., Xin, Y., Chai, J., Dong, Z., Targher, G., Byrne, C. D., He, N., Mi, M., Ye, F., Wai-Sun Wong, V., Pavlides, M., Zheng, M.-H. & Zhang, J., 2 Oct 2024, (E-pub ahead of print) In: Clinical Gastroenterology and Hepatology.

    Research output: Contribution to journal › Article › peer-review

View all 250 research outputs
View all 48 projects